Avalon globocare to present its s-layer and qty code breakthrough technology platforms at the prestigious annual world stem cell summit

Freehold, n.j., june 08, 2021 (globe newswire) -- avalon globocare corp. (nasdaq: avco) (avalon or the company), a clinical-stage global developer of cell-based technologies and therapeutics, today announces that the company's president and chief executive officer, david jin, m.d., ph.d., will chair a session on the “hot topics and future trends” track at the 2021 annual world stem cell summit, which will take place virtually on june 14-18, 2021. the session will feature avalon's two breakthrough technology platforms, s-layer nanotechnology and qty code, in co-development with the massachusetts institute of technology (mit) and the university of natural resources and life sciences in vienna (boku), respectively.
AVCO Ratings Summary
AVCO Quant Ranking